8
Saturday March 1, 201413.30 - 15.00. P l e n a r y S e s s i o n
INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Téot
LEG ULCER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> Why Compression in Leg Ulcers? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Partsch
> Cell and Tissue Therapy for Refractory Leg Ulcers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Kirsner
SCAR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> Recent Advancement of Total Scar Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Ogawa
> New Therapeutic Targets for the Control of Scarring . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Mustoe
15.00 - 15.30. C o f f e e B r e a k
15.30 - 17.00. P l e n a r y S e s s i o n
DIABETIC FOOT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> The Key to Diabetic Limb Salvage: Biomechanics, Biomechanics, Biomechanics . . . . . . . . . . . . . . . . . . . . . . . . . C. Attinger
> Microbiology of Diabetic Foot Infection: What’s New? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Lipsky
TRAUMA/BURNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> Optimizing Burn Treatment in Developing Low and Middle-Income Countries (lMICS)with Limited Health Care Resources . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Atiyeh
> Esthetic and Functional Burn Wound Management and Regeneration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Akita
PRESSURE ULCERS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> The Skin Microclimate in Patients with Pressure Ulcers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Romanelli
> Pressure Ulcers in Geriatrics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Meaume
17.00 - 18.30. S y m p o s i u m
18.30. W e l c o m e c o c k t a i l
Sunday March 2, 201408.30 - 10.00. P l e n a r y S e s s i o n
DIABETIC FOOT PREVENTION AND MANAGEMENT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> Diabetic Limb Salvage: the Keys to Adequate Wound Bed Preparation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Attinger
> Reconstructing with Free Flaps (Supermicrosurgery) for Diabetic Foot . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.P. Hong
> New Innovations in Diabetic Wound Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.P.S. Suri
10.00 - 10.30. C o f f e e B r e a k
10.30 - 12.00. P a r a l l e l S e s s i o n s
SW1. BURNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> 30 Years of Experience of Management of Burns in an Arabic Country . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.A. Nefzi
> Special Types of Burns: Chemical, Electrical, Radiological, Sunburns, Friction Burns, Frostbites . . . . O. Castana
> The Role of Fasciocutaneous Flaps in Solving the Problems of Postburn Severe Contractures . . . . . . . . . M. Kadry
> Brazilian Kiss Nightclub Disaster . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Atiyeh
SC1. CELL BASED THERAPIES AND ENERGY BASED TECHNOLOGY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Bassetto*
> Gingival Fibroblasts Based Therapy for Tissue Repair and Remodeling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Coulomb
> Laser and Radiation Therapy for Scars and Keloids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Ogawa
> Stem Cells for Reduction of Scarring: Challenges, Current Usage, and Experimental Evidence . . . . . . . . T. Mustoe
LU1. LOWER LIMB VASCULAR ASSESSMENT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> Vascular Assessment of the Lower Limb in a Wound Clinic: What to Do and What to Avoid . . . . . . . . . . . . . . . . . R. Mani
> Bedside Vascular Assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Meaume
> Novel Assessment Techniques: Skin Perfusion Pressure and Spy Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Kirsner
> Wound and Skin Diagnostics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Dini
SW2. CANCER WOUNDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> Similarities Between Tumor Stroma Generation and Wound Healing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Desmoulière
> Reconstructive Strategy for Cancer Wounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.S. Granick
> Management of Malignant Wounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Fromantin
> Limitation of Treating Malignant Wounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Akita
Pre-program
DFU: Diabetic Foot Ulcer. LU: Leg Ulcer. SC: Scar. SW: Specific Wounds. (*): Speaker to be confirmed.
Middle East Wounds and Scar Meeting1-3 MARCH 2014 • DUBAI WORLD TRADE CENTER, DUBAI
12.00 - 13.30. L u n c h / C o u r s e s o r O r a l C o m m u n i c a t i o n s
13.30 - 15.00. P a r a l l e l S e s s i o n s
SC2. WOUND MECHANO TRANSDUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . W. Liu, K. Malaker
> Importance of Mechanical Force Reduction in Scar Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Ogawa
> The Impact of Tension on Scarring: Surgical Techniques to Minimize Scar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Mustoe
SW3. BONE AND TENDON EXPOSURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Gurtner, L. Téot
> From Negative Pressure Therapy with Scaffolds to Free Flaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.P. Hong
> Management of Traumatic Tendon and Bone Exposure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.S. Granick
LU2. COMPRESSION BANDAGES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> Skin Management under Compression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Romanelli
> Classification of Compression Bandages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Partsch
> Non Vascular Factors of Calf Muscle Pump Function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Kirsner
DFU1. FUNCTIONAL WOUND CLOSURE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> Soft Tissue Closure Techniques for the Diabetic Foot: How to Choose BetweenSimple and Complex Closures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Attinger
> The Holistic Care of Diabetic Foot in Emerging Asian Country . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H.K. Nair
> Wounds in Hands . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.O.H. Prasetyono*
> Facial and Joint Wound Closure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Akita
15.00 - 15.30. C o f f e e B r e a k
15.30 - 17.00. P a r a l l e l S e s s i o n s
SW4. STOMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> Digestive Stomas and Their Skin Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. van den Bulck
> Bangkok Experience of Transgender - Surgery Related Wounding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Chuangsuwanich*
SW5. DIABETIC FOOT ULCER EDUCATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Téot
> DFU in a Multidisciplinary Center Function. Is Education required? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Gottrup
> Pairing Physician Education Along with Patient Education in Developing Countries . . . . . . . . . . . . . . . . . . . . . . H. Gawish
> Education as an Integrated Part of a Diabetic Foot Ulcer Prevention Strategy:Lessons to be Learned . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Apelqvist
DFU2. WOUND MARKERS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> Keratinocyte Biomarker Predict Healing in DFUs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Kirsner
> Establishing a Newly-set-up Wound Care in Taiwan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Y.R. Kuo
> Histopathological Markers in Diabetic Foot Ulcers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Dini
> Expression of Fibrocyte Markers by Keloid Fibroblasts - An Insight into Fibrosis duringWound Healing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Babu
SC3. SURGERY EVALUATION: EPIDERMAL CONTROL OF SCARRING . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Téot
> Control of Scarring by Telomere Manipulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.S. Granick
> Silicone Gel and other Methods of Occlusion: Their Impact on Epidermal Inflammatory Signalling,and Reduction in Scarring . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Mustoe
> Application of Surgery & Basic Practice of Wound Management for Epidermal Controlof Scarring: Cases & Evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Al Azrak
17.00 - 18.30. S y m p o s i u m
Monday March 3, 201408.30 - 10.00. P a r a l l e l S e s s i o n s
SW6. OPEN ABDOMEN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> Management Principles of Open Abdomen and Complex Abdominal Wounds . . . . . . . . . . . . . . . . . . . . . . . R. van den Bulck
> Negative Pressure Wound Therapy for the Open Abdomen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Koulermou
LU3. VASCULAR WOUNDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> Antimicrobials in Infected Wounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Gottrup
> Standard Care and the Essentials of Management of Vascular Wounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Mani
> Neuroischemic Diabetic Foot Ulcers: Where are We Now? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Apelqvist
> Inflammation and Thrombi of Wounds: Vasculitis and Vasculopathy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Kirsner
Pre-program
DFU: Diabetic Foot Ulcer. LU: Leg Ulcer. SC: Scar. SW: Specific Wounds. (*): Speaker to be confirmed.
Middle East Wounds and Scar Meeting1-3 MARCH 2014 • DUBAI WORLD TRADE CENTER, DUBAI
Middle East Wounds and Scar Meeting1-3 MARCH 2014 • DUBAI WORLD TRADE CENTER, DUBAI
SC4. CURRENT CLINICAL TRIALS CTGF, ANTISENSE, NEODYNE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Gurtner
DFU3. FUNCTIONAL AMPUTATION AND PREVENTION OF TISSUE LOSS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> Optimizing Function and Decreasing Recidivism by Individualizing Amputation for Each Patient . . . C. Attinger
> Application of Vascular Flow in Reconstruction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.P. Hong
> Can Functional Amputation be Avoided? How? Scar Variations in Reconstruction . . . . . . . . . . . . . . . . . M. Ramakrishnan
> Importance of Vascularity in Wound Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Villa
10.00 - 10.30. C o f f e e B r e a k
10.30 - 12.00. P a r a l l e l S e s s i o n s
SW7. PRESSURE ULCERS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> Pressure Ulcer Prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.S. Granick
> Avoidable and Unavoidable Pressure Ulcers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Ghanimé
> Electrical Stimulation in Pressure Sores . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Ricci
> Heel Pressure Ulcers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Meaume
SC5. REGENERATIVE SCIENCE: ZEBRAFISH, SALAMANDER, PLANARIA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Gurtner
DFU4. NEUROPATHY AND CHARCOT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Ertugrul
> Roles of Innervation During Normal and Pathological Healing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Desmoulière
> Osteoartropathy in the Neuropathic Diabetic Foot: An Underestimated Entity . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Apelqvist
SW8. PRACTICE GUIDELINES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> The Importance of Practical Education, Training and Guidelines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Gottrup
> The Role of Technology in Wound Management - The Need for an Optimal Strategy . . . . . . . . . . . . . . . . . . . . . . . . R. Mani
> Guideline in Practice and Theory in Wound Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Akita
12.00 - 13.30. L u n c h / O r a l C o m m u n i c a t i o n s
12.30 - 13.30. M e e t i n g o f W U W H S , M B C , W o u n d A s s o c i a t i o n s a n dA r a b G o v e r n m e n t H e a l t h R e p r e s e n t a t i v e s
13.30 - 15.00. P l e n a r y S e s s i o n
RECOMMENDATIONS ON PRACTICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
> The Algorithm for Lower Extremity Reconstruction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.P. Hong
> The New Diabetic Foot Infection Guidelines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Lipsky
> Compression Therapy in Mixed, Arterial-Venous Leg Ulcers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Partsch
15.00 - 15.30. C o f f e e B r e a k
15.30 - 17.00. P l e n a r y S e s s i o n
TELEMEDICINE AND WOUNDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Téot
> Application of Mobile System in Wound Healing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.P. Hong
> The Status of Telemedicine in the US . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.S. Granick
> Urgent Alarming System by Percutaneous Monitoring System in Free Flap Reconstruction . . . . . . . . . . . . . . S. Akita
Pre-program
DFU: Diabetic Foot Ulcer. LU: Leg Ulcer. SC: Scar. SW: Specific Wounds. (*): Speaker to be confirmed.
Invited Speakers
S. Akita - JapanM. Al Azrak - EgyptJ. Apelqvist - SwedenC. Attinger - United StatesB. Atiyeh - LebanonM. Babu - IndiaF. Bassetto* - ItalyR. van den Bulck - BelgiumO. Castana - GreeceA. Chuangsuwanich* - ThailandB. Coulomb - France
A. Desmoulière - FranceV. Dini - ItalyB. Ertugrul - TurkeyI. Fromantin - FranceH. Gawish - EgyptG. Ghanimé - LebanonF. Gottrup - DenmarkM.S. Granick - United StatesG. Gurtner - United StatesJ.P. Hong - South KoreaM. Kadry - Egypt
R. Kirsner - United StatesG. Koulermou - CyprusY.R. Kuo - TaiwanB. Lipsky - United KingdomW. Liu - ChinaK. Malaker - DominicaR. Mani - United KingdomS. Meaume - FranceT. Mustoe - United StatesH.K. Nair - MalaysiaA.A. Nefzi - Tunisia
R. Ogawa - JapanH. Partsch - AustriaT.O.H. Prasetyono* - IndonesiaM. Ramakrishnan - IndiaE. Ricci - ItalyM. Romanelli - ItalyA.P.S. Suri - IndiaL. Téot - FranceM. Villa - Philippines
Middle East Wounds and Scar Meeting1-3 MARCH 2014 • DUBAI WORLD TRADE CENTER, DUBAI
Map of Dubai
WELCOME TO DUBAI
Capitalising on its central location between east and west,Dubai has expanded rapidly over the past decades withits economy now based around trade, manufacturing andtourism. Liberal regulatory conditions, free zones such asDubai Media City, Dubai Internet City and DubaiInternational Financial Centre plus excellent transportlinks have made the emirate the natural location for regio-nal head offices for multinational companies as well aslocal enterprises.
But the 'Merchants' City' is about far more than business.Safe, tolerant and cosmopolitan, Dubai is an extraordinaryleisure destination. It offers a wealth of amenities, from pris-
tine beaches and world-class hotels to upscale golf coursesand first-class restaurants. 'The City of Gold' provides abroad spectrum of shopping experiences. Renowned forits ultra-modern shopping malls selling the latest designerlabels, it also boasts myriad souqs (traditional market-places) selling everything from gold to spices. Dubai pre-sents a kaleidoscope of past and present. Wind towers sitbeside glittering skyscrapers, desert dunes roll into greengolf courses whilst luxury yachts sail the wind alongsidetraditional dhows. Against a backdrop of a carefully pre-served heritage, Dubai is building a visionary future. Theworld's tallest tower, Burj Khalifa, has been completed,The Palm is a trio of man-made projects, and the first sincethe Great Wall of China to be visible from space.
Middle East Wounds and Scar Meeting1-3 MARCH 2014 • DUBAI WORLD TRADE CENTER, DUBAI
Practical Information
DUBAI: PRACTICAL INFORMATION
Business Hours: > Business: Sunday to Thursday. 8am-1pm and 4pm-7:30pm > Government offices: Sunday toThursday, 7:30am-2:30pm > Exchange houses: 10am-10pm > Shopping malls: Sunday to Wednesday 10am-10pm, and, Thursday and Friday 10am-midnight
Climate: The UAE has a sub-tropical, arid climate. May toSeptember is summer, when temperatures range between40C and 48C. However, during the winter months, tem-peratures range from 10C to 30C. Rainfall is predomi-nantly in winter and amounts to some 13cm annually.
Clothing: Summer clothing may be worn for most of theyear but the temperature can drop during the winter. Atthe pool or on the private beaches, swimwear is quiteacceptable, but when in the city and public areas, careshould be taken not to give offence by wearing clothingthat may be considered revealing.
Communications: The international dialling code for in-coming calls is +9714. Calls to and from land-lines withinDubai are free of charge and direct dialling is possible tomore than 170 countries. GPRS and WAP services are alsoavailable. A GSM international roaming service for mobilephones is available for more than 60 countries. If yourcountry isn’t one of them then a service known as “Wasel”is available. Bring your phone or buy it here and purchasea SIM card (available at most supermarkets, petrol stationsand hotels) which enables you to make and receive callsfrom the UAE. Internet services are also available for non-subscribers from regular phone lines.
Convention Center Access: The Dubai InternationalConvention and Exhibition Centre (DICEC) is located in aprime location on Sheikh Zayed Road within the city. TheDubai World Trade Centre metro station connects theDICEC to major landmarks in Dubai, hotels and to theDubai International Airport Terminal 1 & Terminal 3.
Credit cards: American Express, Diners Club, Visa,MasterCard, etc are generally accepted in hotels andshops.
Currency: The monetary unit is the Dirham (AED), whichis divided into 100 fils. It is fixed to the US dollar at acurrent rate of US$1 = Dhs3.675.
Language: The official language is Arabic but English iswidely spoken and understood throughout the country.
Local Time: Gulf Standard Time: + 4 hours GMT
Medical: Medical services in Dubai are of an internatio-nal standard.
Public holidays: Islamic holidays are based on the Hijricalendar which is controlled by the sighting of the moon.As a result the dates of holidays are often confirmed lessthan 24 hours in advance. Some of these are Eid Al Fitr(three days), Eid Al Adha (four days), Al Hejra (one day),Mawlid Al Nabi (one day) and Al Isra Wal Miraj (one day).Fixed dates on the calendar are New Year’s Day (Jan 1)and UAE National Day (Dec 2). The Holy Month of Ramadanfalls from mid August through to mid-September in 2010,and moves backward approximately 10 days every year.
Tipping: Tipping practices are similar to most other partsof the world. Most restaurants include a 10 per cent servicecharge, but tipping in general is at the customer’s discre-tion.
Transportation: Taxis are easily obtainable in Dubai inevery area. Dubai Municipality operates numerous busroutes throughout the emirate, serving the main residen-tial and commercial areas, as well as some destinationsoutside the city. Many hotels provide regular shuttle busesthat follow set routes around Dubai. The newly opened DubaiMetro connects Dubai International Airport to the conven-tion centre, hotels, malls and other major attractions. Carrental companies require a passport copy and a valid inter-national driving licence for all renters coming from: Austria,Belgium, Canada, Denmark, Finland, France, Germany,Greece, Ireland, Italy, Japan, Netherlands, Norway, Spain,Sweden, Switzerland, Turkey, UK and USA. Driving is onthe right hand side of the road.
Visas: Nationals of the following countries do not requirevisas to enter the UAE: Andorra • Australia • Austria •Belgium • Brunei • Denmark • Finland • France • Germany• Greece • Hong Kong • Iceland • Ireland • Italy • Japan• Liechtenstein • Luxembourg • Malaysia • Monaco • NewZealand • Netherlands • Norway • Portugal • San Marino• Singapore • South Korea • Spain • Sweden • Switzerland• United Kingdom • United States of America • Vatican.Should your country not be listed above please check withyour nearest UAE Embassy/Consulate for any updates.
Water: The tap water in Dubai is safe to drink. Locallybottled mineral water is generally served in hotels andrestaurants.
*Our thanks to the Dubai Convention Bureaufor this information.
ABSTRACT INSTRUCTIONS
1• The abstract should be sent by email ([email protected]) or uploaded onto the website:www.woundsandscarmeeting.com or by fax: +33 (0)1 40 07 10 94.
2• The abstract should be written in Word format (95 or higher).3• Abstracts should be submitted in English.4• The entire abstract should be included within the format of one abstract (text to be included within the
format of height 12.5 cm (4.92 inches) and width 9 cm (3.54 inches) and 250 words max.5• The abstract should be single-spaced, using Arial 10 point font, and must be fully justified. DO NOT use
a smaller font, as the abstract will later be reduced to 70% of the size for printing in the abstract book.6• The abstract title (2 lines maximum) should clearly define the content of the paper. In the title use only
bold capital letters and no abbreviations. Do not centre, start at the left margin.7• Type the author’s initials followed by family name, title (MD, PhD, RN, Pod, Phys Ther) followed by the co-
authors’ names (maximum 5), the name and address of the institution for each author, e-mail of the pre-senting author.
8• The email address box should be filled in properly for correspondence purposes.9• Structure the abstract following IMReD (Introduction, Methods, Results, Discussion)
10• In case of support by a grant, please indicate the source of funding. Disclosure must be indicated.11• Charts or graphs should be inserted in the abstract (files from separate software cannot be implemented).12• Number references (if any) in the order in which they appear in the text.13• Indicate the category (topic) into which the abstract should fit in.14• Indicate your choice (poster or oral communication or no preference).
Contact informationFamily name . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . First name . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Title . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Institution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Zip code . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . City . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Country . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Phone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fax number . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Email . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Your abstract should be received by the Conference Secretariat [email protected] January 5th, 2014 or on the web site: www.woundsandscarmeeting.comThe authors will be informed of the Scientific Committee’s decision before January 30th, 2014.
Please indicate your choice ❏ Poster ❏ Oral Communication ❏ No preference
CALL FOR PAPERS
Middle East Wounds and Scar Meeting1-3 MARCH 2014 • DUBAI WORLD TRADE CENTER, DUBAI
❏ Find enclosed a cheque/bank draftmade payable to MF CONGRESfor: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . €
❏ Find enclosed the copy of the banktransfer.Payable to MF CONGRESfor: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . €
❏ Payment by credit card
❏ MASTERCARD ❏ VISA ❏ AMEX
Expiry date Cryptogram
Registration form
Cancellation Policy
Secretariat 8, rue Tronchet - 75008 Paris - FRANCE Phone: +33 (0)1 40 07 11 21 – Fax: +33 (0)1 40 07 10 94 – Email: [email protected]
Pre-registration before February 14, 2014. After February 14, 2014 registration on site
Registration cancellations must be notified before the 15-01-2014. There will be no refunds for cancellations received afterthis date. A processing fee of € 75 will be charged for all cancellations. Refunds will be processed after the meeting.
Registration fees Before After Jan. 30 2014 Jan. 30 2014
Physicians: ❏ €3501 ❏ €3901
2.5 days 1. Includes 1 year’s subscription to the Journal of Wound Technology
All other health professionals (e.g. nurse, therapist, etc.):2.5 days ❏ €2801 ❏ €3101
Medical intern/resident: (proof required) ❏ €1801 ❏ €1801
2.5 days 1. Includes 1 year’s subscription to the Journal of Wound Technology
Hotel Ibis. Sheikh Zayed Road – Dubai – United Arab Emirates❏ Single : €99 x___ (night(s)) ❏ Double : €109 x___ (night(s))
Hotel Novotel. 2nd Za’abeel Rd – Dubai – United Arab Emirates❏ Single : €134 x___ (night(s)) ❏ Double : €145 x___ (night(s))
Date of arrival: _______________ =______________
❏ Faculty dinner: € 150 x_______________=_______________
TOTAL = €
Registration online: www.woundsandscarmeeting.com
Professional address■ Pr ■ Dr ■ Mr ■ Mrs ■ Miss
Speciality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Family name . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
First name . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Postcode . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
City . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Country . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Phone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Email . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
BANK ACCOUNT: 17515 CODE POSITION: 90000 CODE ACCOUNT: 08001901529 N°KEY: 41 DOMICILIATION: CE ILE-DE-FRANCE
IBAN: FR76 1751 5900 0008 0019 0152 941 – BIC: CEPAFRPP751
BANQUE: CAISSE D’ÉPARGNE PARIS MAGENTA
Signature:Price includes breakfast
Middle East Wounds and Scar Meeting1-3 MARCH 2014 • DUBAI WORLD TRADE CENTER, DUBAI
1. Includes 1 year’s subscription to the Journal of Wound Technology
